A 2mm chip helped a blind patient read a word again
Science Corporation implanted a 2mm chip into a blind patient's eye. By the second rehab session, he could read a word.
Research · Source: TechCrunch
What happened
Max Hodak took the stage at TechCrunch Disrupt to announce a major milestone. His company, Science Corporation, implanted its PRIMA chip into a patient with Stargardt disease. This inherited condition destroys central vision and currently has no cure. It affects roughly 150,000 people worldwide. The surgery took place in May at Sydney Eye Hospital in Australia. PRIMA is already available in Europe for severe age-related macular degeneration, but this is a first for Stargardt disease.
The hardware is tiny but powerful. Surgeons placed a two-millimeter by two-millimeter chip in the back of the patient's eye during a one-hour procedure. The patient wears special camera-equipped glasses that beam visual data directly to the implant. The chip acts like artificial photoreceptors. It translates video into electrical signals that the optic nerve can understand. Hodak noted that vision is ultimately just electrical potential to the brain.
The early results are striking. During the first rehabilitation session, the patient recognized a single letter. By the second session, he read a full word. The vision is not normal sight. Hodak says it is like looking through a straw. The patient sees a small, black-and-white patch in his central vision. But the image is sharp and high-contrast. The company plans to put a next-generation chip into human trials next year to expand the field of view.
Key facts
- 2mm by 2mm — Size of the PRIMA chip implanted in the eye
- 150,000 — People worldwide who have lost vision to Stargardt disease
- 1 hour — Length of the surgical procedure to implant the chip
- 5 years — Timeline to reach near-native visual acuity
Why it matters
Brain-computer interfaces are moving from sci-fi concepts to viable medical products. Hodak left Neuralink to build Science Corporation with a very different philosophy. Instead of drilling directly into brain tissue immediately, they are starting with the retina. The retina is technically part of the central nervous system. By treating vision as an electrical signaling problem, they are proving their technology stack works. This allows them to build a sustainable business and generate revenue while pursuing their broader ambitions.
The long-term roadmap goes far beyond restoring sight. Science Corporation plans to put sensors inside the skull, resting on top of the brain rather than inside the tissue. They want to tackle neurodegenerative diseases and stroke recovery. Hodak even suggested they could add entirely new cortical areas to replace dead brain tissue. The ultimate goal is engineering brains to extend human health span. The company believes that while healthy young people might not need this, brain-computer interfaces will become standard hardware for people in their sixties and seventies.
For builders
Start with a viable business model
Science Corporation wants to build general brain-computer interfaces. But they started with specific eye diseases to prove their methods and establish a sustainable business. Founders must find a narrow problem to fund their massive long-term vision. Patients win by getting treatment, and the company wins by surviving.
Hardware constraints force creative workarounds
The current chip is only two millimeters wide because it must accommodate the natural curvature of the eye. To expand the field of view, engineers must shrink the electrodes even further. Hardware builders must design around the strict physical limits of the human body.
Redefine the interface layer
The company treats the optic nerve as a biological data cable. They bypass dead photoreceptors and send electrical potentials directly to the brain. Engineers should look for ways to bypass broken systems by translating data into a format the next layer already understands.
My take
I love that Hodak is shipping real products instead of just hyping brain implants. Starting with the retina is a brilliant wedge strategy to prove the tech without drilling into brain tissue. This is how you build deep tech. You solve a devastating problem today to fund the sci-fi future of tomorrow.
Original reporting: TechCrunch. This is my rewrite and opinion.